- “When you are good [at your work], you must apologize.” Italian academia.
- no effect of omega-3
- clinical trials of new MS therapy go ahead in spite of MS society disapproval. Canadian MS society leaders have managed to convince themselves it could be bad to learn more about a plausible and possibly revolutionary therapy for MS. “A true clinical trial must be conducted at more than one institution and in more than one province” with “well over 1000 participants,” said Yves Savoie, the president of the Canadian MS society. If a study had only 999 participants, he would disapprove of it!
Thanks to Casey Manion and Anne Weiss